Vantage Point: Driving Success in the Australian Market
We sit down with CEOs and top business personalities to discuss their journey to success.
Vantage Point: Driving Success in the Australian Market
A Californian Cancer Killer Professor Yuman Fong and his work with Imugene
•
Simon Hinsley
•
Season 1
•
Episode 6
Professor Yuman Fong is co-inventor of the CF33 oncolytic virus, a technology that has been licensed to Imugene (ASX:IMU).
He’s the Chairman of the Department of Surgery at City of Hope Cancer Centre in California. He’s an internationally recognised expert in pancreatic and liver cancer, as well as having developed many new surgical techniques and instruments.
Ahead of his presentation as the keynote speaker at the Bioshares Biotech Summit, he joined us for episode 6 of NWR’s Vantage Point podcast.